Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer (LBDL)
Gastric Cancer Stage II, Gastric Cancer Stage III
About this trial
This is an interventional treatment trial for Gastric Cancer Stage II focused on measuring Laparoscopic, Bursectomy, D2 lymphadenectomy, Gastric Cancer
Eligibility Criteria
Inclusion Criteria:
- The age limits is 18-80 years old;
- T3-T4 resectable gastric carcinoma,confirmed by CT and pathology.
- The preoperative imaging confirmed that the tumor did not involve adjacent organs;
- American Society of anesthesiologists (ASA) score less than or equal to Level 3;
- Criteria of performance status karnofsky is greater than or equal to 60.
Exclusion Criteria:
- The patients' age limits is Less than 18 years old, or more than 80 years old;
- The preoperative imaging confirmed that the tumor involve adjacent organs;
- The tumor have been finding distant metastases;
- American Society of anesthesiologists (ASA) score more than 3;
- Criteria of performance status karnofsky is lower than 60;
- There is a laparoscopic surgery contraindications.
Sites / Locations
- GI surgery,Guangdong Provincial Hospital of Traditional Chinese MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
The bursectomy and D2 lymphadenectomy
The D2 lymphadenectomy
Laparoscopic bursectomy and D2 lymphadenectomy will be performed for the treatment of patients assigned to this group.The key of this approach are that anterior lobe of transverse mesocolon and capsula pancreatis will be dissected with the D2 lymphadenectomy according to the guidelines of National Comprehensive Cancer Network(NCCN)
Laparoscopic D2 lymphadenectomy will be performed for the treatment of patients assigned to this group.The key of this approach is that D2 lymphadenectomy is carried out according to the guidelines of National Comprehensive Cancer Network(NCCN) without dissociation of anterior lobe of transverse mesocolon and capsula pancreatis.